LUNG SQUAMOUS CELL CARCINOMA STAGE IV

This adverse event was reported 67 times

LUNG SQUAMOUS CELL CARCINOMA STAGE IV is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 PEGFILGRASTIM-CBQV 1 0.0007
1 CEVIMELINE HYDROCHLORIDE 1 0.0004
2 BASILIXIMAB 4 0.0003
3 BARICITINIB 1 0.0003
4 TIGECYCLINE 2 0.0003
5 CHLORAMBUCIL 1 0.0003
6 CARBOXYMETHYLCELLULOSE SODIUM 1 0.0002
7 BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - CHERRY 1 0.0002
8 MAGNESIUM CITRATE ORAL SOLUTION 1 0.0002
9 MAGNESIUM CITRATE 1 0.0002
See all drugs enriched for association with LUNG SQUAMOUS CELL CARCINOMA STAGE IV